{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:41:48Z","timestamp":1793036508449,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA264984"],"award-info":[{"award-number":["R01CA264984"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA014236"],"award-info":[{"award-number":["P30CA014236"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA280499"],"award-info":[{"award-number":["R21CA280499"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018866","name":"Paula and Rodger Riney Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018866","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41375-025-02522-9","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T14:37:01Z","timestamp":1738247821000},"page":"720-733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Targeting ABCD1-ACOX1-MET\/IGF1R axis suppresses multiple myeloma"],"prefix":"10.1038","volume":"39","author":[{"given":"Zhannan","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhehan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3693-2522","authenticated-orcid":false,"given":"Yihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9619-7156","authenticated-orcid":false,"given":"Maja","family":"Beus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren B.","family":"Weidenhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Lakhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Civils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina M.","family":"Furdui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8630-7430","authenticated-orcid":false,"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhard","family":"Bieberich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9436-8815","authenticated-orcid":false,"given":"Lawrence H.","family":"Boise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7868-0518","authenticated-orcid":false,"given":"Mikhail A.","family":"Nikiforov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"2522_CR1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","volume":"97","author":"SV Rajkumar","year":"2022","unstructured":"Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97:1086\u2013107.","journal-title":"Am J Hematol"},{"key":"2522_CR2","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3390\/curroncol30020179","volume":"30","author":"P Bhatt","year":"2023","unstructured":"Bhatt P, Kloock C, Comenzo R. Relapsed\/Refractory Multiple Myeloma: A Review of Available Therapies and Clinical Scenarios Encountered in Myeloma Relapse. Curr Oncol. 2023;30:2322\u201347.","journal-title":"Curr Oncol"},{"key":"2522_CR3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10555-017-9707-8","volume":"36","author":"S Gandolfi","year":"2017","unstructured":"Gandolfi S, Laubach JP, Hideshima T, Chauhan D, Anderson KC, Richardson PG. The proteasome and proteasome inhibitors in multiple myeloma. Cancer Metastasis Rev. 2017;36:561\u201384.","journal-title":"Cancer Metastasis Rev"},{"key":"2522_CR4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/oncolo\/oyad306","volume":"29","author":"A Rafae","year":"2024","unstructured":"Rafae A, van Rhee F, Al Hadidi S. Perspectives on the Treatment of Multiple Myeloma. Oncologist. 2024;29:200\u201312.","journal-title":"Oncologist"},{"key":"2522_CR5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ctrv.2018.09.001","volume":"70","author":"P Robak","year":"2018","unstructured":"Robak P, Drozdz I, Szemraj J, Robak T. Drug resistance in multiple myeloma. Cancer Treat Rev. 2018;70:199\u2013208.","journal-title":"Cancer Treat Rev"},{"key":"2522_CR6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7:11\u201320.","journal-title":"Cell Metab"},{"key":"2522_CR7","doi-asserted-by":"crossref","unstructured":"Weir P, Donaldson D, McMullin MF, Crawford L. Metabolic alterations in multiple myeloma: from oncogenesis to proteasome inhibitor resistance. Cancers. 2023;15:1682.","DOI":"10.3390\/cancers15061682"},{"key":"2522_CR8","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1182\/bloodadvances.2020002578","volume":"5","author":"BC Lipchick","year":"2021","unstructured":"Lipchick BC, Utley A, Han Z, Moparthy S, Yun DH, Bianchi-Smiraglia A, et al. The fatty acid elongase ELOVL6 regulates bortezomib resistance in multiple myeloma. Blood Adv. 2021;5:1933\u201346.","journal-title":"Blood Adv"},{"key":"2522_CR9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41375-020-0962-2","volume":"35","author":"J Longo","year":"2021","unstructured":"Longo J, Smirnov P, Li Z, Branchard E, van Leeuwen JE, Licht JD, et al. The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma. Leukemia. 2021;35:796\u2013808.","journal-title":"Leukemia"},{"key":"2522_CR10","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1007\/s10238-023-01174-2","volume":"23","author":"R Torcasio","year":"2023","unstructured":"Torcasio R, Gallo Cantafio ME, Ikeda RK, Ganino L, Viglietto G, Amodio N. Lipid metabolic vulnerabilities of multiple myeloma. Clin Exp Med. 2023;23:3373\u201390.","journal-title":"Clin Exp Med"},{"key":"2522_CR11","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Ortiz A, Rodr\u00edguez-Garc\u00eda Y, Encinas J, Maroto-Mart\u00edn E, Castellano E, Teixid\u00f3 J, et al. The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression. Cancers. 2021;13:217.","DOI":"10.3390\/cancers13020217"},{"key":"2522_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43556-024-00188-w","volume":"5","author":"Q Lu","year":"2024","unstructured":"Lu Q, Yang D, Li H, Niu T, Tong A. Multiple myeloma: signaling pathways and targeted therapy. Mol Biomed. 2024;5:25.","journal-title":"Mol Biomed"},{"key":"2522_CR13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.seminoncol.2022.01.005","volume":"49","author":"A Bolomsky","year":"2022","unstructured":"Bolomsky A, Young RM. Pathogenic signaling in multiple myeloma. Semin Oncol. 2022;49:27\u201340.","journal-title":"Semin Oncol"},{"key":"2522_CR14","first-page":"923","volume":"4","author":"P Giannoni","year":"2021","unstructured":"Giannoni P, de Totero D. The HGF\/c-MET axis as a potential target to overcome survival signals and improve therapeutic efficacy in multiple myeloma. Cancer Drug Resist. 2021;4:923\u201333.","journal-title":"Cancer Drug Resist"},{"key":"2522_CR15","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1586\/14737159.2015.1046436","volume":"15","author":"M Gambella","year":"2015","unstructured":"Gambella M, Palumbo A, Rocci A. MET\/HGF pathway in multiple myeloma: from diagnosis to targeted therapy? Expert Rev Mol Diagn. 2015;15:881\u201393.","journal-title":"Expert Rev Mol Diagn"},{"key":"2522_CR16","doi-asserted-by":"crossref","unstructured":"Heredia-Guerrero SC, Evers M, Keppler S, Schwarzfischer M, Fuhr V, Rauert-Wunderlich H, et al. Functional Investigation of IGF1R Mutations in Multiple Myeloma. Cancers. 2024;16:2139.","DOI":"10.3390\/cancers16112139"},{"key":"2522_CR17","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.18632\/oncotarget.12123","volume":"8","author":"D Vishwamitra","year":"2017","unstructured":"Vishwamitra D, George SK, Shi P, Kaseb AO, Amin HM. Type I insulin-like growth factor receptor signaling in hematological malignancies. Oncotarget. 2017;8:1814\u201344.","journal-title":"Oncotarget"},{"key":"2522_CR18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41587-020-0481-8","volume":"38","author":"E Dolgin","year":"2020","unstructured":"Dolgin E. IGF-1R drugs travel from cancer cradle to Graves. Nat Biotechnol. 2020;38:385\u20138.","journal-title":"Nat Biotechnol"},{"key":"2522_CR19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40291-021-00568-w","volume":"26","author":"Y Dong","year":"2022","unstructured":"Dong Y, Xu J, Sun B, Wang J, Wang Z. MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review. Mol Diagn Ther. 2022;26:203\u201327.","journal-title":"Mol Diagn Ther"},{"key":"2522_CR20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.taap.2012.01.007","volume":"259","author":"KS George","year":"2012","unstructured":"George KS, Wu S. Lipid raft: A floating island of death or survival. Toxicol Appl Pharmacol. 2012;259:311\u20139.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2522_CR21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbamem.2008.07.030","volume":"1788","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Li X, Becker KA, Gulbins E. Ceramide-enriched membrane domains-structure and function. Biochim Biophys Acta. 2009;1788:178\u201383.","journal-title":"Biochim Biophys Acta"},{"key":"2522_CR22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/5584_2022_759","volume":"1436","author":"OA Isik","year":"2023","unstructured":"Isik OA, Cizmecioglu O. Rafting on the Plasma Membrane: Lipid Rafts in Signaling and Disease. Adv Exp Med Biol. 2023;1436:87\u2013108.","journal-title":"Adv Exp Med Biol"},{"key":"2522_CR23","volume":"55","author":"B Li","year":"2022","unstructured":"Li B, Qin Y, Yu X, Xu X, Yu W. Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis. Cell Prolif. 2022;55:e13167.","journal-title":"Cell Prolif"},{"key":"2522_CR24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc3277","volume":"12","author":"JB Casaletto","year":"2012","unstructured":"Casaletto JB, McClatchey AI. Spatial regulation of receptor tyrosine kinases in development and cancer. Nat Rev Cancer. 2012;12:387\u2013400.","journal-title":"Nat Rev Cancer"},{"key":"2522_CR25","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bbamem.2017.01.025","volume":"1859","author":"EV Bocharov","year":"2017","unstructured":"Bocharov EV, Sharonov GV, Bocharova OV, Pavlov KV. Conformational transitions and interactions underlying the function of membrane embedded receptor protein kinases. Biochim Biophys Acta Biomembr. 2017;1859:1417\u201329.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"2522_CR26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1194\/jlr.TR120000658","volume":"61","author":"D Sviridov","year":"2020","unstructured":"Sviridov D, Mukhamedova N, Miller YI. Lipid rafts as a therapeutic target. J Lipid Res. 2020;61:687\u201395.","journal-title":"J Lipid Res"},{"key":"2522_CR27","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/BJ20111837","volume":"443","author":"S Tsukamoto","year":"2012","unstructured":"Tsukamoto S, Hirotsu K, Kumazoe M, Goto Y, Sugihara K, Suda T, et al. Green tea polyphenol EGCG induces lipid-raft clustering and apoptotic cell death by activating protein kinase C\u03b4 and acid sphingomyelinase through a 67 kDa laminin receptor in multiple myeloma cells. Biochem J. 2012;443:525\u201334.","journal-title":"Biochem J"},{"key":"2522_CR28","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0006-291X(02)02311-2","volume":"297","author":"D Scheel-Toellner","year":"2002","unstructured":"Scheel-Toellner D, Wang K, Singh R, Majeed S, Raza K, Curnow SJ, et al. The death-inducing signalling complex is recruited to lipid rafts in Fas-induced apoptosis. Biochem Biophys Res Commun. 2002;297:876\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"2522_CR29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.cdd.4401434","volume":"11","author":"A Berthier","year":"2004","unstructured":"Berthier A, Lemaire-Ewing S, Prunet C, Monier S, Athias A, Bess\u00e8de G, et al. Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ. 2004;11:897\u2013905.","journal-title":"Cell Death Differ"},{"key":"2522_CR30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2249.2005.02720.x","volume":"139","author":"E Janas","year":"2005","unstructured":"Janas E, Priest R, Wilde JI, White JH, Malhotra R. Rituxan (anti-CD20 antibody)-induced translocation of CD20 into lipid rafts is crucial for calcium influx and apoptosis. Clin Exp Immunol. 2005;139:439\u201346.","journal-title":"Clin Exp Immunol"},{"key":"2522_CR31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1182\/blood-2006-04-016824","volume":"109","author":"C Gajate","year":"2007","unstructured":"Gajate C, Mollinedo F. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. Blood. 2007;109:711\u20139.","journal-title":"Blood"},{"key":"2522_CR32","doi-asserted-by":"crossref","first-page":"e8532","DOI":"10.1371\/journal.pone.0008532","volume":"4","author":"ZX Xu","year":"2009","unstructured":"Xu ZX, Ding T, Haridas V, Connolly F, Gutterman JU. Avicin D, a plant triterpenoid, induces cell apoptosis by recruitment of Fas and downstream signaling molecules into lipid rafts. PLoS One. 2009;4:e8532.","journal-title":"PLoS One"},{"key":"2522_CR33","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1038\/onc.2009.183","volume":"28","author":"M Reis-Sobreiro","year":"2009","unstructured":"Reis-Sobreiro M, Gajate C, Mollinedo F. Involvement of mitochondria and recruitment of Fas\/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions. Oncogene. 2009;28:3221\u201334.","journal-title":"Oncogene"},{"key":"2522_CR34","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1038\/onc.2010.131","volume":"29","author":"F Mollinedo","year":"2010","unstructured":"Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, Campanero MA, et al. Lipid raft-targeted therapy in multiple myeloma. Oncogene. 2010;29:3748\u201357.","journal-title":"Oncogene"},{"key":"2522_CR35","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.bbamem.2016.04.014","volume":"1858","author":"Y Li","year":"2016","unstructured":"Li Y, Gao L, Tan X, Li F, Zhao M, Peng S. Lipid rafts-mediated endocytosis and physiology-based cell membrane traffic models of doxorubicin liposomes. Biochim Biophys Acta. 2016;1858:1801\u201311.","journal-title":"Biochim Biophys Acta"},{"key":"2522_CR36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631165","volume":"12","author":"R Kulkarni","year":"2021","unstructured":"Kulkarni R, Wiemer EAC, Chang W. Role of Lipid Rafts in Pathogen-Host Interaction - A Mini Review. Front Immunol. 2021;12:815020.","journal-title":"Front Immunol"},{"key":"2522_CR37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4062\/biomolther.2014.017","volume":"22","author":"T Sassa","year":"2014","unstructured":"Sassa T, Kihara A. Metabolism of very long-chain Fatty acids: genes and pathophysiology. Biomol Ther. 2014;22:83\u201392.","journal-title":"Biomol Ther"},{"key":"2522_CR38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2004.08.016","volume":"83","author":"RJ Wanders","year":"2004","unstructured":"Wanders RJ. Peroxisomes, lipid metabolism, and peroxisomal disorders. Mol Genet Metab. 2004;83:16\u201327.","journal-title":"Mol Genet Metab"},{"key":"2522_CR39","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6786245","volume":"2016","author":"K Kawaguchi","year":"2016","unstructured":"Kawaguchi K, Morita M. ABC Transporter Subfamily D: Distinct Differences in Behavior between ABCD1-3 and ABCD4 in Subcellular Localization, Function, and Human Disease. Biomed Res Int. 2016;2016:6786245.","journal-title":"Biomed Res Int"},{"key":"2522_CR40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.biochem.74.082803.133329","volume":"75","author":"RJ Wanders","year":"2006","unstructured":"Wanders RJ, Waterham HR. Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem. 2006;75:295\u2013332.","journal-title":"Annu Rev Biochem"},{"key":"2522_CR41","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1750-3639.2010.00391.x","volume":"20","author":"S Kemp","year":"2010","unstructured":"Kemp S, Wanders R. Biochemical aspects of X-linked adrenoleukodystrophy. Brain Pathol. 2010;20:831\u20137.","journal-title":"Brain Pathol"},{"key":"2522_CR42","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/humu.20535","volume":"28","author":"S Ferdinandusse","year":"2007","unstructured":"Ferdinandusse S, Denis S, Hogenhout EM, Koster J, van Roermund CW, IJlst L, et al. Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency. Hum Mutat. 2007;28:904\u201312.","journal-title":"Hum Mutat"},{"key":"2522_CR43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jb\/mvs105","volume":"152","author":"A Kihara","year":"2012","unstructured":"Kihara A. Very long-chain fatty acids: elongation, physiology and related disorders. J Biochem. 2012;152:387\u201395.","journal-title":"J Biochem"},{"key":"2522_CR44","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1074\/jbc.M116.763532","volume":"292","author":"J Zeng","year":"2017","unstructured":"Zeng J, Deng S, Wang Y, Li P, Tang L, Pang Y. Specific Inhibition of Acyl-CoA Oxidase-1 by an Acetylenic Acid Improves Hepatic Lipid and Reactive Oxygen Species (ROS) Metabolism in Rats Fed a High Fat Diet. J Biol Chem. 2017;292:3800\u20139.","journal-title":"J Biol Chem"},{"key":"2522_CR45","volume":"299","author":"H Yao","year":"2023","unstructured":"Yao H, Wang Y, Zhang X, Li P, Shang L, Chen X, et al. Targeting peroxisomal fatty acid oxidation improves hepatic steatosis and insulin resistance in obese mice. J Biol Chem. 2023;299:102845.","journal-title":"J Biol Chem"},{"key":"2522_CR46","doi-asserted-by":"crossref","first-page":"486","DOI":"10.7150\/thno.22059","volume":"8","author":"YH Lai","year":"2018","unstructured":"Lai YH, Liu H, Chiang WF, Chen TW, Chu LJ, Yu JS, et al. MiR-31-5p-ACOX1 Axis Enhances Tumorigenic Fitness in Oral Squamous Cell Carcinoma Via the Promigratory Prostaglandin E2. Theranostics. 2018;8:486\u2013504.","journal-title":"Theranostics"},{"key":"2522_CR47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41421-022-00515-x","volume":"9","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Yang X, Wu J, Ye S, Gong J, Cheng WM, et al. Reprogramming of palmitic acid induced by dephosphorylation of ACOX1 promotes \u03b2-catenin palmitoylation to drive colorectal cancer progression. Cell Discov. 2023;9:26.","journal-title":"Cell Discov"},{"key":"2522_CR48","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41375-023-02103-8","volume":"38","author":"M Tannoury","year":"2024","unstructured":"Tannoury M, Ayoub M, Dehgane L, Nemazanyy I, Dubois K, Izabelle C, et al. ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia. Leukemia. 2024;38:302\u201317.","journal-title":"Leukemia"},{"key":"2522_CR49","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108421","volume":"33","author":"S Shen","year":"2020","unstructured":"Shen S, Faouzi S, Souquere S, Roy S, Routier E, Libenciuc C, et al. Melanoma Persister Cells Are Tolerant to BRAF\/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation. Cell Rep. 2020;33:108421.","journal-title":"Cell Rep"},{"key":"2522_CR50","doi-asserted-by":"crossref","first-page":"917","DOI":"10.18632\/aging.100512","volume":"4","author":"S Mannava","year":"2012","unstructured":"Mannava S, Moparthy KC, Wheeler LJ, Leonova KI, Wawrzyniak JA, Bianchi-Smiraglia A, et al. Ribonucleotide reductase and thymidylate synthase or exogenous deoxyribonucleosides reduce DNA damage and senescence caused by C-MYC depletion. Aging. 2012;4:917\u201322.","journal-title":"Aging"},{"key":"2522_CR51","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fcell.2019.00166","volume":"7","author":"X Jiang","year":"2019","unstructured":"Jiang X, Zhu Z, Qin H, Tripathi P, Zhong L, Elsherbini A, et al. Visualization of Ceramide-Associated Proteins in Ceramide-Rich Platforms Using a Cross-Linkable Ceramide Analog and Proximity Ligation Assays With Anti-ceramide Antibody. Front Cell Dev Biol. 2019;7:166.","journal-title":"Front Cell Dev Biol"},{"key":"2522_CR52","doi-asserted-by":"crossref","first-page":"17753","DOI":"10.1021\/acs.jmedchem.1c00944","volume":"64","author":"JH Come","year":"2021","unstructured":"Come JH, Senter TJ, Clark MP, Court JJ, Gale-Day Z, Gu W, et al. Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1. J Med Chem. 2021;64:17753\u201376.","journal-title":"J Med Chem"},{"key":"2522_CR53","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02664-y","volume":"19","author":"B Zierfuss","year":"2022","unstructured":"Zierfuss B, Buda A, Villoria-Gonz\u00e1lez A, Logist M, Fabjan J, Parzer P, et al. Saturated very long-chain fatty acids regulate macrophage plasticity and invasiveness. J Neuroinflammation. 2022;19:305.","journal-title":"J Neuroinflammation"},{"key":"2522_CR54","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Pascau L, Vilalta A, Cerrada M, Traver E, Forss-Petter S, Weinhofer I, et al. The brain penetrant PPAR\u03b3 agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy. Sci Transl Med. 2021;13:eabc0555.","DOI":"10.1126\/scitranslmed.abc0555"},{"key":"2522_CR55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","volume":"343","author":"J Kr\u00f6nke","year":"2014","unstructured":"Kr\u00f6nke J, Udeshi ND, Narla A, Grauman P, Hurst SN, McConkey M, et al. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science. 2014;343:301\u20135.","journal-title":"Science"},{"key":"2522_CR56","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.bbalip.2014.01.001","volume":"1841","author":"Y Abe","year":"2014","unstructured":"Abe Y, Honsho M, Nakanishi H, Taguchi R, Fujiki Y. Very-long-chain polyunsaturated fatty acids accumulate in phosphatidylcholine of fibroblasts from patients with Zellweger syndrome and acyl-CoA oxidase1 deficiency. Biochim Biophys Acta. 2014;1841:610\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"2522_CR57","volume":"15","author":"D Lu","year":"2024","unstructured":"Lu D, He A, Tan M, Mrad M, El Daibani A, Hu D, et al. Liver ACOX1 regulates levels of circulating lipids that promote metabolic health through adipose remodeling. Nat Commun. 2024;15:4214.","journal-title":"Nat Commun"},{"key":"2522_CR58","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neuron.2020.02.021","volume":"106","author":"HL Chung","year":"2020","unstructured":"Chung HL, Wangler MF, Marcogliese PC, Jo J, Ravenscroft TA, Zuo Z, et al. Loss- or Gain-of-Function Mutations in ACOX1 Cause Axonal Loss via Different Mechanisms. Neuron. 2020;106:589\u2013606.e6.","journal-title":"Neuron"},{"key":"2522_CR59","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.bbalip.2013.06.001","volume":"1831","author":"Y Ishibashi","year":"2013","unstructured":"Ishibashi Y, Kohyama-Koganeya A, Hirabayashi Y. New insights on glucosylated lipids: metabolism and functions. Biochim Biophys Acta. 2013;1831:1475\u201385.","journal-title":"Biochim Biophys Acta"},{"key":"2522_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbo.2015.01.001","volume":"4","author":"AI S\u00e9galiny","year":"2015","unstructured":"S\u00e9galiny AI, Tellez-Gabriel M, Heymann MF, Heymann D. Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers. J Bone Oncol. 2015;4:1\u201312.","journal-title":"J Bone Oncol"},{"key":"2522_CR61","doi-asserted-by":"crossref","first-page":"13793","DOI":"10.1074\/jbc.272.21.13793","volume":"272","author":"PE Bickel","year":"1997","unstructured":"Bickel PE, Scherer PE, Schnitzer JE, Oh P, Lisanti MP, Lodish HF. Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J Biol Chem. 1997;272:13793\u2013802.","journal-title":"J Biol Chem"},{"key":"2522_CR62","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/membranes4030356","volume":"4","author":"M Meister","year":"2014","unstructured":"Meister M, Tikkanen R. Endocytic trafficking of membrane-bound cargo: a flotillin point of view. Membranes. 2014;4:356\u201371.","journal-title":"Membranes"},{"key":"2522_CR63","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113195","volume":"42","author":"A Honda","year":"2023","unstructured":"Honda A, Nozumi M, Ito Y, Natsume R, Kawasaki A, Nakatsu F, et al. Very-long-chain fatty acids are crucial to neuronal polarity by providing sphingolipids to lipid rafts. Cell Rep. 2023;42:113195.","journal-title":"Cell Rep"},{"key":"2522_CR64","doi-asserted-by":"crossref","first-page":"17250","DOI":"10.1074\/jbc.270.29.17250","volume":"270","author":"EP Kilsdonk","year":"1995","unstructured":"Kilsdonk EP, Yancey PG, Stoudt GW, Bangerter FW, Johnson WJ, Phillips MC, et al. Cellular cholesterol efflux mediated by cyclodextrins. J Biol Chem. 1995;270:17250\u20136.","journal-title":"J Biol Chem"},{"key":"2522_CR65","doi-asserted-by":"crossref","first-page":"1r","DOI":"10.1093\/glycob\/cwl052","volume":"17","author":"S Sonnino","year":"2007","unstructured":"Sonnino S, Mauri L, Chigorno V, Prinetti A. Gangliosides as components of lipid membrane domains. Glycobiology. 2007;17:1r\u201313r.","journal-title":"Glycobiology"},{"key":"2522_CR66","doi-asserted-by":"crossref","unstructured":"de Groot S, R\u00f6ttgering B, Gelderblom H, Pijl H, Szuhai K, Kroep JR Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma. Cancers. 2020;12:3568.","DOI":"10.3390\/cancers12123568"},{"key":"2522_CR67","doi-asserted-by":"crossref","unstructured":"Rivas S, Mar\u00edn A, Samtani S, Gonz\u00e1lez-Feli\u00fa E, Armis\u00e9n R MET Signaling Pathways, Resistance Mechanisms, and Opportunities for Target Therapies. Int J Mol Sci. 2022;23:13898.","DOI":"10.3390\/ijms232213898"},{"key":"2522_CR68","doi-asserted-by":"crossref","unstructured":"Outhwaite IR, Singh S, Berger BT, Knapp S, Chodera JD, Seeliger MA Death by a thousand cuts through kinase inhibitor combinations that maximize selectivity and enable rational multitargeting. Elife. 2023;12:e86189.","DOI":"10.7554\/eLife.86189"},{"key":"2522_CR69","volume":"298","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang X, Yao H, Chen X, Shang L, Li P, et al. Peroxisome-generated succinate induces lipid accumulation and oxidative stress in the kidneys of diabetic mice. J Biol Chem. 2022;298:101660.","journal-title":"J Biol Chem"},{"key":"2522_CR70","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/bjc.2014.307","volume":"111","author":"W Wu","year":"2014","unstructured":"Wu W, Merriman K, Nabaah A, Seval N, Seval D, Lin H, et al. The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma. Br J Cancer. 2014;111:628\u201336.","journal-title":"Br J Cancer"},{"key":"2522_CR71","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1080\/10428194.2021.1933474","volume":"62","author":"I Avivi","year":"2021","unstructured":"Avivi I, Yekutiel N, Cohen I, Cohen YC, Chodick G, Weil C. Diabetes, but not pre-diabetes, is associated with shorter time to second-line therapy and worse outcomes in patients with multiple myeloma. Leuk Lymphoma. 2021;62:2785\u201392.","journal-title":"Leuk Lymphoma"},{"key":"2522_CR72","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/bloodadvances.2023010815","volume":"8","author":"UA Shah","year":"2024","unstructured":"Shah UA, Moshier E, Derkach A, Huang Y, Mailankody S, Tan CR, et al. Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups. Blood Adv. 2024;8:236\u201347.","journal-title":"Blood Adv"},{"key":"2522_CR73","doi-asserted-by":"crossref","unstructured":"Chen XF, Tian MX, Sun RQ, Zhang ML, Zhou LS, Jin L, et al. SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer. EMBO Rep. 2018;19.","DOI":"10.15252\/embr.201745124"},{"key":"2522_CR74","doi-asserted-by":"crossref","first-page":"9044","DOI":"10.1073\/pnas.1105666108","volume":"108","author":"\u00dc Coskun","year":"2011","unstructured":"Coskun \u00dc, Grzybek M, Drechsel D, Simons K. Regulation of human EGF receptor by lipids. Proc Natl Acad Sci USA. 2011;108:9044\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2522_CR75","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s13287-022-03111-8","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Zhu N, Li HF, Gu J, Zhang CJ, Liao DF, et al. The lipid rafts in cancer stem cell: a target to eradicate cancer. Stem Cell Res Ther. 2022;13:432.","journal-title":"Stem Cell Res Ther"},{"key":"2522_CR76","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1158\/1535-7163.MCT-15-0185","volume":"14","author":"S Tsukamoto","year":"2015","unstructured":"Tsukamoto S, Huang Y, Kumazoe M, Lesnick C, Yamada S, Ueda N, et al. Sphingosine Kinase-1 Protects Multiple Myeloma from Apoptosis Driven by Cancer-Specific Inhibition of RTKs. Mol Cancer Ther. 2015;14:2303\u201312.","journal-title":"Mol Cancer Ther"},{"key":"2522_CR77","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09555-6","volume":"10","author":"BG Barwick","year":"2019","unstructured":"Barwick BG, Neri P, Bahlis NJ, Nooka AK, Dhodapkar MV, Jaye DL, et al. Multiple myeloma immunoglobulin lambda translocations portend poor prognosis. Nat Commun. 2019;10:1911.","journal-title":"Nat Commun"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02522-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02522-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02522-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T16:10:53Z","timestamp":1741104653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02522-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["2522"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02522-9","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The study was approved by the Duke University Health System Institutional Review Board (IRB protocol #: Pro00006268) and the Wake Forest University Institutional Review Board (IRB protocol #: IRB00059639). All patients provided written informed consent. All animal experiments were approved by the Duke Institutional Animal Care and Use Committee (IACUC protocol #: A227-21-11-24).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}